Description of Medical Areas
About the FDA Approved Listings
|
 |
Drugs Approved by the FDA (1996)
|
The following drugs have been approved this year by
the Food and Drug Administration.
Cardiology/Vascular Diseases
|
|
Muse; Treatment for impotence; Vivus; Approved October 1996 Retavase (reteplase); Treatment for patients suffering from heart attack; Boehringer Mannheim Corporation; Approved November 1996
Dental/Maxillofacial Surgery
|
|
Dermatology/Plastic Surgery
|
|
Iamin; Gel wound dressing; ProCyte; Approved February 1996 Iontocaine; Needle-free anesthetic; Iomed; Approved May 1996 IvyBlock; Treatment for poison ivy, poison oak, and poison sumac; EnviroDerm Pharmaceuticals; Approved September 1996
Arimidex (anastrozole); Treatment for advanced breast cancer in postmenopausal women; Zeneca Pharmaceuticals; Approved January 1996 Camptosar Injection; Treatment for metastatic colorectal cancer; Pharmacia & Upjohn; Approved June 1996 CEA-Scan; Diagnostic imaging product for colorectal cancer; Immunomedics; Approved April 1996 Confide; HIV testing and counseling service; Johnson & Johnson; Approved May 1996 Estrostep; Treatment for birth control; Parke-Davis; Approved October 1996 FemPatch; Treatment for menopausal symptoms; Parke-Davis; Approved December 1996 Glyset (miglitol); Treatment for Type II (non-insulin-dependent) diabetes mellitus; Bayer; Approved December 1996 Lodine (etodolac); Treatment for rheumatoid arthritis; Wyeth-Ayerst Laboratories; Approved July 1996 Naprelan (naproxen sodium); Treatment for osteoarthritis and rheumatoid arthritis; Elan, Wyeth-Ayerst Laboratories; Approved January 1996 Saizen; Treatment for growth hormone deficiency and Turner Syndrome; Ares-Serono; Approved May 1996 Taxotere (Docetaxel); Treatment for locally advanced or metastatic breast cancer; Rhone Poulenc Rorer; Approved May 1996
Axid AR (nizatidine; Over-the-counter anti-ulcer treatment; Whitehall-Robins Healthcare; Approved May 1996 GastroMARK; Contrast agent for magnetic resonance imaging of the gastrointestinal tract; Advanced Magnetics; Approved May 1996 Merrem I.V. (meropenem); Treatment for intra-abdominal infections and bacterial meningitis; Zeneca Pharmaceuticals; Approved June 1996 Prilosec (omeprazole); Treatment for heartburn, gastroesophageal reflux disease (GERD); Astra Merck; Approved December 1996 Seprafilm; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery; Genzyme; Approved August 1996
Immunology/Infectious Diseases
|
|
Albenza (albendazole); Treatment for parasitic infections caused by worms; SmithKline Beecham; Approved June 1996 Carrington patch; Treatment for canker sores; Carrington Laboratories; Approved May 1996 Confide; HIV testing and counseling service; Johnson & Johnson; Approved May 1996 Havrix; Treatment for hepatitis A; SmithKline Beecham; Approved March 1996 Norvir (ritonavir); Treatment for HIV infection; Abbott Laboratories; Approved March 1996/March 1997 Oral Cytovene; Treatment for the prevention of cytomegalovirus (CMV); Roche; Approved December 1996 Vitrasert Implant; Drug delivery system for the treatment of cytomegalovirus; Chiron Vision; Approved March 1996 Zithromax (azithromycin); Treatment for Mycobacterium avium complex (MAC) in subjects with advanced HIV infection; Pfizer; Approved June 1996
Kadian; Treatment for chronic moderate to severe pain; Purepac Pharmaceutical; Approved July 1996 Naprelan (naproxen sodium); Treatment for osteoarthritis and rheumatoid arthritis; Elan, Wyeth-Ayerst Laboratories; Approved January 1996 Saizen; Treatment for growth hormone deficiency and Turner Syndrome; Ares-Serono; Approved May 1996 Seprafilm; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery; Genzyme; Approved August 1996
Monurol; Treatment for uncomplicated urinary tract infection; Forest Laboratories; Approved December 1996 Seprafilm; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery; Genzyme; Approved August 1996
Anexsia; Treatment for chronic pain; Mallinckrodt Group; Approved August 1996 Iontocaine; Needle-free anesthetic; Iomed; Approved May 1996 Kadian; Treatment for chronic moderate to severe pain; Purepac Pharmaceutical; Approved July 1996 Merrem I.V. (meropenem); Treatment for intra-abdominal infections and bacterial meningitis; Zeneca Pharmaceuticals; Approved June 1996 UltraJect; Treatment for chronic pain; Mallinckrodt Group; Approved August 1996
Arimidex (anastrozole); Treatment for advanced breast cancer in postmenopausal women; Zeneca Pharmaceuticals; Approved January 1996 Estrostep; Treatment for birth control; Parke-Davis; Approved October 1996 FemPatch; Treatment for menopausal symptoms; Parke-Davis; Approved December 1996 Seprafilm; Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery; Genzyme; Approved August 1996 Taxotere (Docetaxel); Treatment for locally advanced or metastatic breast cancer; Rhone Poulenc Rorer; Approved May 1996
Anexsia; Treatment for chronic pain; Mallinckrodt Group; Approved August 1996 Arimidex (anastrozole); Treatment for advanced breast cancer in postmenopausal women; Zeneca Pharmaceuticals; Approved January 1996 Camptosar Injection; Treatment for metastatic colorectal cancer; Pharmacia & Upjohn; Approved June 1996 CEA-Scan; Diagnostic imaging product for colorectal cancer; Immunomedics; Approved April 1996 Feridex I.V.; Contrast agent for magnetic resonance imaging of liver lesions; Advanced Magnetics; Approved February 1996 GastroMARK; Contrast agent for magnetic resonance imaging of the gastrointestinal tract; Advanced Magnetics; Approved May 1996 Kadian; Treatment for chronic moderate to severe pain; Purepac Pharmaceutical; Approved July 1996 Photodynamic Therapy; Photodynamic therapy device for the treatment of esophageal cancer; Sanofi Winthrop, QLT; Approved January, 1996 Taxotere (Docetaxel); Treatment for locally advanced or metastatic breast cancer; Rhone Poulenc Rorer; Approved May 1996 UltraJect; Treatment for chronic pain; Mallinckrodt Group; Approved August 1996
Alphagan (brimonidine); Treatment for open-angle glaucoma and ocular hypertension; Allergan; Approved September 1996 OcuHist; Over-the-counter antihistamine eye drop; Pfizer; Approved January 1996 Vitrasert Implant; Drug delivery system for the treatment of cytomegalovirus; Chiron Vision; Approved March 1996
Havrix; Treatment for hepatitis A; SmithKline Beecham; Approved March 1996 Merrem I.V. (meropenem); Treatment for intra-abdominal infections and bacterial meningitis; Zeneca Pharmaceuticals; Approved June 1996 Norvir (ritonavir); Treatment for HIV infection; Abbott Laboratories; Approved March 1996/March 1997
Iontocaine; Needle-free anesthetic; Iomed; Approved May 1996
NicoDerm CQ; Treatment for smoking cessation; SmithKline Beecham, Hoechst Marion Roussel, Alza; Approved August 1996 Nicotrol NS; Treatment for nicotine addiction; Pharmacia & Upjohn; Approved March 1996 Zyprexa; Treatment of the symptoms of psychotic disorders; Eli Lilly; Approved September 1996
Pulmonary/Respiratory Diseases
|
|
Accolate; Treatment for asthma; Zeneca Pharmaceuticals; Approved October 1996 Astelin nasal spray; Treatment for seasonal allergic rhinitis; Wallace Laboratories; Approved November 1996 Breathe Right; Treatment for breathing difficulties due to deviated nasal septum; CNS; Approved June 1996 OcuHist; Over-the-counter antihistamine eye drop; Pfizer; Approved January 1996 Pulmozyme (dornase alfa); Treatment for cystic fibrosis patients with advanced disease; Genentech; Approved December 1996 Tavist-D; Treatment for cold symptoms; Sandoz Pharmaceuticals; Approved November 1996
Lodine (etodolac); Treatment for rheumatoid arthritis; Wyeth-Ayerst Laboratories; Approved July 1996 Naprelan (naproxen sodium); Treatment for osteoarthritis and rheumatoid arthritis; Elan, Wyeth-Ayerst Laboratories; Approved January 1996
Trauma/Emergency Medicine
|
|
Iamin; Gel wound dressing; ProCyte; Approved February 1996
|
|
Back to Centerwatch Drug Directories
|
